Overview

Preventing Malaria During Pregnancy in Epidemic-prone Areas.

Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
0
Participant gender:
Female
Summary
The purpose of this study is to compare the efficacy and cost-effectiveness of three alternative strategies for the prevention of malaria during pregnancy in an epidemic-prone area of low transmission in the East African Highlands. The strategies being compared are: - intermittent preventive treatment with sulfadoxine-pyrimethamine (IPT-SP) - an insecticide treated net (ITN), and - intermittent preventive treatment with SP plus an ITN In addition to the main individually-randomised trial, outcome data was subsequently also gathered on pregnant women whose houses where sprayed with indoor residual insecticides (IRS) as part of a non-randomised district-wide control programme to compare the impact of IRS with the three intervention arms.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Gates Malaria Partnership
London School of Hygiene and Tropical Medicine
Collaborator:
Ministry of Health, Uganda
Treatments:
Fanasil, pyrimethamine drug combination
Pyrimethamine
Sulfadoxine
Criteria
Inclusion Criteria:

- Pregnant women whose pregnancies are at <27 weeks gestation at first antenatal booking

- Permanent resident in study area

- Informed consent

Exclusion Criteria:

- Late presentation: pregnancies more than 26 weeks gestation at first antenatal booking

- Severe anaemia (Hb<70g/L) on enrolment

- Previous reaction to a sulfa-drug (e.g. sulphadoxine-pyrimethamine, septrin)

- History of severe skin reaction to any drug

- Current (or history) of severe disease (e.g. hepatitis, jaundice, TB, AIDS)

Withdrawal Criteria:

- Withdrawal of consent

- Women developing severe anaemia (Hb<70g/L)during pregnancy